Minimally invasive treatment application of botulinum toxin type A precision injection for hypertrophic scar

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300073981

Enrollment

Unknown

Registered

2023-07-26

Start date

2022-02-10

Completion date

Unknown

Last updated

2023-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertrophic scars

Interventions

BTA group:Botulinum toxin A was microinjected from the scar lesion and the underlying muscle layer

TAC group:Injecting triamcinolone acetonide into scar lesions

CO2 laser group:CO2 lattice laser irradiation on scars

Eligibility

Sex/Gender

All

Age

8 Years to 63 Years

Inclusion criteria

Inclusion criteria: (1)fit HS diagnostic criteria;(2)located in active places with tension;(3)have not accpeted any treatment;(4) No history of muscle weakness and botulinum toxin allergy ,(5)willing to accept treatment with follow-up.

Exclusion criteria

Exclusion criteria: (1) atrophic scarring;(2)pregnant and lactating women ;(3)those with co-morbid underlying conditions.

Design outcomes

Primary

Measure	Time frame
POSAS Scar Evaluation Scale(Patient+Doctor);	—

Secondary

Measure	Time frame
Vancouver Scar Assessment Scale;	—

Countries

China

Contacts

Public ContactBanghong Jiang

The First Affiliated Hospital of Bengbu Medical College

323199460@qq.com+86 150 5637 9979

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026